| 英文名称 | 中文名称 | CAS | MF |
|
RANITIDINE RELATED COMPOUND A 5-[[(2-AMINOETHYL)THIO]METHYL]-N,N-DIMETHYL-2-FURANMETHANAMINE HEMIFUMARATE USP(CRM STANDARD)
|
雷尼替丁相关化合物
|
|
|
|
RANITIDINE HYDROCHLORIDE BP STANDARD(CRM STANDARD)
|
盐酸雷尼替丁
|
|
|
|
RANITIDINE HCL IMP. B (EP): N,N-DIMETHYL-5-(2-AMINOETHYLTHIOMETHYL)FURFURYLAMINE MM(CRM STANDARD)
|
|
|
|
|
RANITIDINE HYDROCHLORIDE*) EPR(CRM STANDARD)
|
|
|
|
|
RANITIDINE HYDROCHLORIDE ASSAY STANDARD BP(CRM STANDARD)
|
盐酸雷尼替丁检测标准品
|
|
C13H23ClN4O3S
|
|
RANITIDINE HCL IMP. C (EP): N-{2-[5-(DIMETHYLAMINOMETHYL)-2-FURYLMETHYLSULPHINYL]ETHYL}-N'-METHYL-2-NITRO-1,1-ETHENDIAMINE (RANITIDINE SULPHOXIDE) MM(CRM STANDARD)
|
|
|
|
|
RANITIDINE HCL IMP. A (EP): N,N'-BIS{2-[5-(DIMETHYLAMINOMETHYL)FURFURYLTHIO]ETHYL}-2-NITRO-1,1-ETHENDIAMINE MM(CRM STANDARD)
|
|
|
|
|
RANITIDINE RELATED COMPOUND C N-[2-[[[5-[(DIMETHYLAMINO)METHYL]-2-FURANYL]METHYL]SULFINYL]ETHYL]-N-METHYL-2-NITRO-1,1-ETHENEDIAMINE USP(CRM STANDARD)
|
|
|
|
|
RANITIDINE HCL IMP. F (EP): 5-(DIMETHYLAMINOMETHYL)FURFURYL ALCOHOL MM(CRM STANDARD)
|
|
|
|
|
RANITIDINE IMPURITY B[[5-[[(2-AMINOETHYL)THIO]METHYL]FURAN-2-YL]METHYL]DIMETHYL AMINE EPR(CRM STANDARD)
|
|
|
C13H22N4O3S
|
|
RANITIDINE HCL IMP. D (EP)AS SODIUM SALT:N-{2-[5-(DIMETHYLAMINOMETHYL)-2-FURFURYLTHIO]ETHYL}-2-NITROACETAMIDE SODIUM SALT MM(CRM STANDARD)
|
|
|
|
|
Ranitidinebismuthcitrate
|
枸橼酸铋雷尼替丁
|
128345-62-0
|
C19H30N4O10S
|
|
rankinidine
|
4-去甲基-胡蔓藤碱乙
|
106466-66-4
|
C20H24N2O3
|
|
RANKINE 350
|
|
|
|
|
(+)-Ramulosin
|
枝盘孢菌素
|
29914-01-0
|
C10H14O3
|
|
Ramulus Mori extract（1-DNJ）
|
桑枝提取物
|
|
|
|
RAMULUSCINNAMOMICASSIAE
|
|
|
|
|
RANK LIGAND SOLUBLE, HUMAN
|
|
|
|
|
RANK PRIMER PAIR
|
|
|
|
|
RANK RECEPTOR, SOLUBLE, HUMAN
|
|
|
|
|
RANK RECEPTOR, HUMAN
|
|
|
|
|
(3R)-3,4,5,5a,6,7,8,9-Octahydro-2,2,5aβ,9β-tetramethyl-2H-3β,9aβ-methano-1-benzoxepin-5α,6,7-triol 5-(3-phenyloxirane-2-carboxylate)6-acetate 7-butanoate
|
|
|
|
|
(2R)-1,2,3,4,6,7,8,8a-Octahydro-8α,8aα-dimethyl-α-methylene-6-oxo-2-naphthaleneacetic acid
|
|
58142-10-2
|
C15H20O3
|
|
(2R)-1,2,3,5,6,7,8,8aβ-Octahydro-1-(4-dimethylaminophenyl)-2β-phenyl-4-(trimethylsilyloxy)quinoline
|
|
|
|
|
(2R)-1,2,3,5,6,7,8,8aβ-Octahydro-1-(4-methoxyphenyl)-2β-phenyl-4-(trimethylsilyloxy)quinoline
|
|
|
|
|
(2R)-1,2,3,4,6,7,8,8a-Octahydro-α,α,8β,8aβ-tetramethyl-2-naphthalenemethanol
|
(2R)-1,2,3,4,6,7,8,8a-Octahydro-α,α,8β,8aβ-tetramethyl-2-naphthalenemethanol
|
20489-45-6
|
C15H26O
|
|
(1R,7aα)-Octahydro-1α-(1-isocyano-2-methyl-1-propenyl)-3aα-methyl-7-methylene-1H-indene
|
|
62078-10-8
|
C16H23N
|
|
(3R)-2,3,4,5,6,7,8,8aβ-Octahydro-6β-hydroxy-3β,6,8-trimethyl-1H-3aα,7α-methanoazulene-8α-carboxylic acid
|
|
18319-38-5
|
C15H24O3
|
|
(1R,3aα)-Octahydro-2α,3α-epoxy-5β,6β,7β-trihydroxy-7aα-(hydroxymethyl)-5-isopropylspiro[1H-indene-1,2'-oxirane]-4β-carboxylic acid 4,6-lactone
|
|
|
|
|
(1R,9aβ)-Octahydro-1α-[(3-methylbutyryloxy)methyl]-2H-quinolizine
|
|
|
|
|
(2R)-1,2,3,5,6,7,8,8aβ-Octahydro-2β-phenyl-4-(trimethylsilyloxy)quinoline
|
|
|
|
|
(1R,9aα)-Octahydro-4β-(3-furyl)-1α-methyl-2H-quinolizine
|
|
|
|
|
[1R,3aβ,(+)]-Octahydro-4-oxo-7β,7aβ-dimethyl-1H-indene-1α-carboxylic acid methyl ester
|
|
|
|
|
(3R,4aβ)-Octahydro-2,2,5,8aα-tetramethyl-3α,5α-ethano-2H-1-benzopyran
|
|
53840-54-3
|
C15H26O
|
|
(2R)-2,3,4,4a,5,6,7,8-Octahydro-α,α,4aβ,8β-tetramethyl-2-naphthalenemethanol
|
|
63891-61-2
|
C15H26O
|
|
(3R,4aα)-Octahydro-6α-bromo-7β-hydroxy-3α,8aα-dimethylnaphthalen-1(2H)-one
|
|
|
|
|
(1R)-1,2,3,5,6,7,8,8a-Octahydro-1α,8aα-dimethyl-7β-(1-methylethyl)naphthalene
|
|
28940-75-2
|
C15H26
|
|
[3R,(-)]-2,3,4,5,6,7,8,8aβ-Octahydro-1H-5β,6β-epoxy-3aα,7α-methano-3,6,8,8-tetramethylazulene
|
|
|
|
|
(2R)-1,2,3,5,6,7,8,8aβ-Octahydro-2β-phenyl-1-trimethylsilyl-4-(trimethylsilyloxy)quinoline
|
|
|
|
|
(1R,7aα)-Octahydro-7-methylcyclopenta[c]pyran-1α,4aα,5α,7α-tetrol
|
|
|
|
|
(1R,3aβ)-Octahydro-7β,7aβ-dimethyl-4α-[[(1S,4R)-3-oxo-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptan-1-yl]carbonyloxy]-1H-indene-1α-carboxylic acid methyl ester
|
|
|
|
|
(3R)-3,4,5,6,6aα,7,8,9-Octahydro-2,2,6α,9β-tetramethyl-3,9aβ-methano-2H-cyclopent[b]oxocin-5α-ol
|
|
21764-23-8
|
C15H26O2
|
|
(5R)-1,2,3,5,6,7,8,8aβ-Octahydro-5α-hexylindolizine
|
|
|
|
|
(2R)-1,2,3,5,6,7,8,8aβ-Octahydro-1,2β-diphenyl-4-(trimethylsilyloxy)quinoline
|
|
|
|
|
(3R)-2,3,4,5,6,7,8,8a-Octahydro-6α,8aα-dimethyl-3α-(1-methylethyl)azulen-3aα(1H)-ol
|
|
22007-94-9
|
C15H28O
|
|
(1R)-1,2,3,4,4aα,5,6,7-Octahydro-4β-methyl-7-methylene-1β-isopropylnaphthalene
|
|
|
|
|
(3R)-3,4,5,5a,6,7,8,9-Octahydro-2,2,5aβ,9β-tetramethyl-2H-3β,9aβ-methano-1-benzoxepine-5α,6β,7β-triol 5,7-diacetate 6-cinnamate
|
|
|
|
|
(3R)-3,4,5,5a,6,7,8,9-Octahydro-2,2,5aβ,9β-tetramethyl-2H-3β,9aβ-methano-1-benzoxepine-5α,6β,7β-triol
|
|
59812-47-4
|
C15H26O4
|
|
(1R,9aα)-Octahydro-4β-(3-furyl)-1,7β-dimethyl-2H-quinolizine 5α-oxide
|
(+)-萍蓬汀
|
468-89-3
|
C15H23NO2
|
|
(1R,9aα)-Octahydro-2H-quinolizine-1α-ol
|
|
|
|
|
(1R,9aβ)-Octahydro-1α-[(3-phenylacryloyloxy)methyl]-2H-quinolizine
|
|
|
|
|
(3R,7aα)-Octahydro-7α-acetoxy-3aα-hydroxy-3α-(hydroxymethyl)-1,1,3,5α-tetramethyl-1H-indene-4β-carboxylic acid
|
|
75207-64-6
|
C17H28O6
|
|
(3R,5aβ)-Octahydro-2,2,5a,9β-tetramethyl-9H-3β,9aβ-methano-1-benzoxepin-5α,6β,7β-triol 5-cinnamate 6-acetate 7-(2-methylbutanoate)
|
|
|
|
|
(1R,7aα)-Octahydro-1α-(1-isothiocyanato-2-methyl-1-propenyl)-3aα-methyl-7-methylene-1H-indene
|
|
62078-11-9
|
C16H23NS
|
|
[2R,(-)]-1,2,3,4,6,7,8,8a-Octahydro-5,8aβ-dimethyl-3-(1-methylethylidene)naphthalene-2β-ol
|
|
97530-58-0
|
C15H24O
|
|
(3R)-3,4,5,5a,6,7,8,9-Octahydro-2,2,5aβ,9β-tetramethyl-2H-3β,9aβ-methano-1-benzoxepin-5α,6,7-triol 5-(3-phenyloxirane-2-carboxylate)6,7-diacetate
|
|
|
|
|
(2R)-1,2,3,4,4a,5,6,7-Octahydro-4aα,8-dimethyl-β-methylene-2α-naphthaleneethanol
|
|
65018-14-6
|
C15H24O
|
|
(2R)-1,2,3,4,4a,5,6,7-Octahydro-4aα,8-dimethyl-α-methylene-2α-naphthaleneacetic acid
|
|
|
|
|
(3R)-3,4,5,5a,6,7,8,9-Octahydro-2,2,5aβ,9β-tetramethyl-2H-3β,9aβ-methano-1-benzoxepin-5α,6,7-triol 5-(3-phenyloxirane-2-carboxylate)6-acetate 7-benzoate
|
|
|
|
|
(4R,9aβ)-Octahydro-4-methyl-2H-quinolizine-2-one
|
|
66835-10-7
|
C10H17NO
|
|
(3R)-3,4,5,6,6aα,7,8,9-Octahydro-2,2,6α,9β-tetramethyl-3,9aβ-methano-2H-cyclopent[b]oxocin
|
|
21764-22-7
|
C15H26O
|
|
(2R)-1,2,3,5,6,7,8,8aβ-Octahydro-1-benzyl-2β-phenyl-4-(trimethylsilyloxy)quinoline
|
|
|
|
|
(1R,9aβ)-Octahydro-1α-[(tert-butylcarbonyloxy)methyl]-2H-quinolizine
|
|
|
|
|
(3R)-3,4,5,5a,6,7,8,9-Octahydro-2,2,5aβ,9β-tetramethyl-2H-3β,9aβ-methano-1-benzoxepin-5α,6-diol 5-(3-phenyloxirane-2-carboxylate)6-acetate
|
|
|
|
|
(2R)-1,2,3,4,6,7,8,8a-Octahydro-8β,8aβ-dimethyl-3-methylene-5H-2β,4aβ-ethanonaphthalen-5-one
|
|
28895-19-4
|
C15H22O
|
|
(2R)-1,2,3,5,6,7,8,8aβ-Octahydro-1-(4-methylphenyl)-2β-phenyl-4-(trimethylsilyloxy)quinoline
|
|
|
|
|
(2R)-1,2,3,5,6,7,8,8a-Octahydro-5α,8aβ-dimethyl-3-(1-methylethylidene)naphthalen-2β-ol acetate
|
|
105708-62-1
|
C17H26O2
|
|
(3R)-2,3β,4,5,6,7,8,8aβ-Octahydro-6β-hydroxy-6,8,8-trimethyl-1H-3aα,7α-methanoazulene-3β-carboxylic acid
|
|
60237-70-9
|
C15H24O3
|
|
(1R)-1,2,3,4,4aα,5,6,7-Octahydro-1α,6-dimethyl-4α-(1-methylethyl)-6β-isothiocyanonaphthalene
|
|
|
|
|
(3R,10bβ)-Dodecahydro-3α-ethenyl-3,4aα,7,7,10aα-pentamethyl-9H-naphtho[2,1-b]pyran-9β-ol
|
|
|
|
|
(3R,10bβ)-Dodecahydro-3-ethenyl-3,4aα,7,7,10aα-pentamethyl-1H-naphtho[2,1-b]pyran-8α-ol formate
|
|
|
|
|
(3R,10bβ)-Dodecahydro-3α-ethenyl-3,4aα,7,7,10aα-pentamethyl-9H-naphtho[2,1-b]pyran-9-one
|
|
|
|
|
(3R,10bβ)-Dodecahydro-3-ethenyl-3,4aα,7,7,10aα-pentamethyl-1H-naphtho[2,1-b]pyran-8α-ol acetate
|
|
|
|
|
Ranolazine Bis(N-Oxide)
|
雷诺拉嗪BIS(N氧化物)
|
1246816-00-1
|
C24H33N3O6
|
|
Ranolazine β-D-Glucuronide (Mixture of diastereoMers)
|
|
|
C30H41N3O10
|
|
Ranolazine 2,3,4-Tri-O-isobutyryl-β-D-Glucuronide Methyl Ester (Mixture of diastereoMers)
|
Ranolazine 2,3,4-Tri-O-isobutyryl-β-D-Glucuronide Methyl Ester (Mixture of diastereoMers)
|
|
C43H61N3O13
|
|
Ranolazine,Angina
|
|
|
|
|
Ranolazine
|
多司马酯
|
122312-55-4
|
C28H61Al16O79S8
|
|
ranolazine
|
雷诺嗪
|
110445-25-5
|
C24H33N3O4
|
|
RanolazineHydrochloride
|
|
|
|
|
Ranolazine
|
雷诺嗪
|
95635-55-5
|
C24H33N3O4
|
|
Ranolazine-d5
|
|
1092804-87-9
|
C24H28D5N3O4
|
|
Ranolazine-d3
|
N-(2,6-二甲基苯基)-4-[2-羟基-3-[2-(三氘甲基)苯氧基]丙基]-1-哌嗪乙酰胺
|
1054624-77-9
|
C24H33N3O4
|
|
Ranolazine dihydrochloride
|
盐酸雷诺嗪
|
95635-56-6
|
C24H35Cl2N3O4
|
|
RanolazineBase
|
|
|
|
|
Ranolazine
|
雷诺嗪
|
142387-99-3
|
C24H33N3O4
|
|
(4R)-A(1)-Nor-2,3-seco-D:A-friedooleanane-2,3,24-trioic acid trimethyl ester
|
|
43230-22-4
|
C32H52O6
|
|
Rb97D protein
|
|
|
|
|
(R)-(+)-Befunolol
|
|
66685-75-4
|
C16H21NO4
|
|
RAN (Q69L), HUMAN
|
|
|
|
|
Ran Q69L, Human, Recombinant, E. coli
|
|
|
|
|
RAP94
|
|
|
|
|
rAp53
|
|
|
|
|
rans-2-MethylaMino-1-phenyl-3-cyclohexene-1-carboxylic Acid Acyl-β-D-glucuronide
|
|
|
|
|
RANTES (3-68) (human)
|
RANTES (3-68) (HUMAN)
|
|
|
|
RANTES RECOMBINANT EXPRESSED IN E.COLI 50NG ML 98+%
|
|
|
|
|
RANTES, Murine (Regulated on Activation, Normal T-cell Expressed and Secreted)
|
|
|
|
|
RANTES, Recombinant, Rat (Regulated on Activation, Normal T-cell Expressed and Secreted)
|
|
|
|
|
RANTES, Human (Regulated on Activation, Normal T-cell Expressed and Secreted), High & Low Control
|
|
|
|
|
RANTES, Human, Recomb.
|
|
|
|